MAPK3 and colorectal cancer: Although ERK1/2 activity counteracts the damages induced by an acute increase in intracellular calcium [45], in colorectal cancer, the oncogenic activation of BRAF/MEK/ERK1/2 induces a chronic ER stress that promotes cell survival and is associated with tumor progression and poor patient outcome [92].